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Abstract
Rare individuals with inactivating mutations in the Huntington’s disease gene (HTT) exhibit
variable abnormalities that imply essential HTT roles during organ development. Here we
report phenotypes produced when increasingly severe hypomorphic mutations in the murine
HTT orthologue Htt, (HdhneoQ20, HdhneoQ50, HdhneoQ111), were placed over a null allele
(Hdhex4/5). The most severe hypomorphic allele failed to rescue null lethality at gastrulation,
while the intermediate, though still severe, alleles yielded recessive perinatal lethality and a
variety of fetal abnormalities affecting body size, skin, skeletal and ear formation, and tran-
sient defects in hematopoiesis. Comparative molecular analysis of wild-type and Htt-null ret-
inoic acid-differentiated cells revealed gene network dysregulation associated with organ
development that nominate polycomb repressive complexes and miRNAs as molecular
mediators. Together these findings demonstrate that Htt is required both pre- and post-gas-
trulation to support normal development.
Author summary
The HTT gene mutated in Huntington’s Disease (HD) has essential roles during normal
development. However, still not fully understood are the functional consequences of its
partial inactivation. Our genetic study provides a comprehensive description of the effects
of progressively more severe decreases in expression of Htt, the murine HTT counterpart.
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The most severe Htt decrease leads to lethality of early embryos, while intermediate but
still severely reduced Htt dosages yield a variety of recessively inherited developmental
abnormalities affecting body size, skin, skeletal and ear formation, and hematopoiesis.
Comparative molecular analysis of differentiating wild-type cells and cells lacking Htt
function further elucidate genes networks dysregulated during organ development. These
nominate chromatin regulators and short non-coding RNAs as key molecular mediators.
Together these findings demonstrate that Htt is required from conception to support nor-
mal embryonic and fetal development.
Introduction
Huntington’s Disease (HD) is a dominantly inherited neurodegenerative disorder character-
ized by motor, cognitive and behavioral signs, generally of mid-life onset [1]. HD is caused by
an unstable CAG trinucleotide repeat expansion in the 4p16.3 gene HTT (previously HD) [2].
The size of the expanded repeat is strongly correlated with age at onset but genetic variants at
other loci, including DNA maintenance genes involved in somatic repeat instability, can mod-
ify the rate of pathogenesis [3].
Though knowledge of the pathogenic rate driver is emerging from HD genetic studies, it is
not yet evident which aspect of the HTT expansion mutation is harmful to the cellular targets
whose dysfunction or demise contributes to the disorder. The observation that CAG repeat
expansions at different unrelated genes yield distinct neurological disorders argues that the
harmful entity may be at the level of the HTT-encoded protein (huntingtin), through some
opportunity afforded by the mutant protein’s normal function [4]. Consistent with this
hypothesis, HD CAG expansion homozygotes exhibit onset similar to HD heterozygotes [5]
and HTT inactivating mutations do not produce HD. Instead, rare humans with a single func-
tional HTT copy [6], and mice with a single functional HTT orthologue (Htt, previously Hdh),
whether a wild-type or a CAG repeat knock-in allele [7–9], are unremarkable. By contrast,
complete inactivation of both alleles is early embryonic lethal [7,10,11].
The essential role played by HTT early in development is hypothesized, from genetic studies
in the mouse, to intersect with chromatin regulation, influencing for example, the histone
methyltransferase polycomb repressive complex 2 (PRC2) [12–14], although the lethality of
null alleles has hampered studies later in development [7]. However, a recent report of a family
segregating two rare, apparently incompletely inactivating HTT mutations [15,16], emphati-
cally demonstrates that HTT is also essential for proper development of the brain and possibly
other organs, as compound heterozygote children exhibit variable neurodevelopmental fea-
tures, including motor disturbance, hypotonia, abnormal cranial circumference and small stat-
ure, as well as early death (OMIM: 617435) [16]. These observations are generally consistent
with findings from genetic studies with members of a hypomorphic allelic series of flox-
pGKneo-in CAG repeat knock-in mouse lines. HdhneoQ20, HdhneoQ50 and HdhneoQ111 mice
carry a mild, intermediate and severe hypomorphic neo-in allele, respectively, as judged by
immunoblot analysis of cultured ES cells and brain tissue [8,9,17,18]. Compound heterozy-
gotes with combinations of these alleles, as well as homozygotes, exhibit a number of evident,
variable abnormalities, involving brain development, movement deficits, decreased body size
and reduced survival [9,17,18].
We have systematically evaluated each of the neo-in CAG repeat knock-in alleles for the
ability to support proper development when placed over the same Hdhex4/5 null allele in order
to assess the extent to which dosage of the HD gene mouse orthologue, below a single
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functional copy, is essential for normal development and to uncover processes sensitive to
gene dosage. Our findings, augmented by molecular analysis of Hdhex4/5 embryonic stem cells
(ESC) and retinoic acid differentiated cells, indicate that in addition to the brain, the proper
development of several other organ systems requires huntingtin, as revealed by different reces-
sive developmental blocks that are by-passed at different dosages. Our data also highlight
potentially responsible regulatory factors and networks that are sensitive to inactivating muta-
tion of Htt.
Results
HdhneoQ20, HdhneoQ50, HdhneoQ111 hypomorphic mutation and Hdhex4/5
null rescue
HdhneoQ20, HdhneoQ50 and HdhneoQ111 mice were bred to Hdhex4/5 mice, with a targeted null
allele [7], and their progeny were genotyped at weaning and at earlier stages, to assess the abil-
ity of each hypomorphic allele to rescue the early embryonic lethality at ~E7.5–8.0 imposed by
complete gene inactivation. The results, summarized in Tables 1–3, indicate the expected Men-
delian ratio for progeny with wild-type alleles, at all ages, but revealed lethality for hypomorph
mutation hemizygotes (with the Hdhex4/5 null allele) beginning at progressively earlier stages
with increased severity of inactivation. The HdhneoQ20/Hdhex4/5 diplotype was recovered at the
expected Mendelian ratio at E14.5 and embryos appeared normal, while the HdhneoQ50/ex4/5 was
recovered at the expected Mendelian ratio at E10-12.5 but the embryos were smaller than wild-
type. Finally, the HdhneoQ111/Hdhex4/5 diplotype was seen at E8.5, though all embryos had the
abnormal sock-like appearance of Hdhex4/5/Hdhex4/5 null embryos just post-gastrulation, lacking
head-folds (Fig 1A). HdhneoQ111/Hdhex4/5 embryos (non-resorbed) were not observed at later
stages. HdhneoQ20/Hdhex4/5 and HdhneoQ50/Hdhex4/5 survivors were recovered at later stages but
these died perinatally and at birth, respectively, displaying abnormalities that increased in sever-
ity with the gradient of inactivation HdhneoQ20/Hdhex4/5 <HdhneoQ50/Hdhex4/5: dome shaped
cranium-to-overt exencephaly and mild-to-robustly decreased height and weight (Fig 1A–1E).
HdhneoQ20/Hdhex4/5 and HdhneoQ50/Hdhex4/5 have deficits in multiple organ
systems
In previous studies of Hdhex4/5/Hdhex4/5 null embryos, embryoid bodies (EBs), as well as cul-
tured ESC and neuronal cells, we demonstrated that a functional Htt allele is required for
proper PRC2 activity, during genome-wide deposition of H3K27me3 epigenetic chromatin
marks [12,13]. We therefore surveyed HdhneoQ20/Hdhex4/5 and HdhneoQ50/Hdhex4/5 embryos,
mainly at E18.5, to evaluate a number of organ systems whose development is reported to
require appropriate PRC2 activity and/or proper activity of its co-regulator polycomb repres-
sive complex 1 (PRC1). Skeletal elements, ear development, skin barrier formation and fetal
liver hematopoiesis were assessed.
Skeleton
HdhneoQ20/Hdhex4/5 and HdhneoQ50/Hdhex4/5 embryos exhibited lumbar to sacral (L6 to the S1)
vertebral transformation whose penetrance (20% and 30%, respectively) increased with the
severity of inactivation. This abnormality was not observed in embryos with one wild-type
allele (Fig 2A, Table 4). In addition, 50% of HdhneoQ20/Hdhex4/5 and 62.5% of HdhneoQ50/
Hdhex4/5 embryos but none of the embryos with a wild-type allele displayed variable abnormali-
ties of the sternum and xyphoid process (Fig 2B, Table 4), although the phenotypes were dis-
tinct. The HdhneoQ50/Hdhex4/5 xyphoid process was narrow, with reduced ossification, while the
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HdhneoQ20/Hdhex4/5 process was fenestrated. Furthermore, the tip of the HdhneoQ50/Hdhex4/5
sternum was bent inward, perhaps to accommodate a narrower thoracic cavity (Fig 2B,
Table 4). The cervical vertebrae gap (C1 to C2 gap) was abnormally increased in 100% of
HdhneoQ50/Hdhex4/5 embryos, perhaps secondary to the domed cranium and/or exencephaly
(Fig 2C and 2D, Table 4). Variable hyoid bone and cartilage defects also increased with severity
of the inactivating allele, such that 62% of HdhneoQ50/Hdhex4/5 and 10% of HdhneoQ20/Hdhex4/5
embryos had an abnormally short hyoid bone, greater horns and abnormal thyroid and cricoid
cartilage morphology or spacing of the thyroid cartilage relative to the hyoid bone, respectively
(Fig 2E, Table 4).
Ear
External ear and middle ear structures were also abnormal, increasing with the severity of the
mutant allele: 100% of HdhneoQ50/Hdhex4/5 embryos had (bilateral) hypoplastic pinna and
Table 1. Related to Fig 1 phenotypes. The table summarizes the total number of animals per litter and the percentages of normal and abnormal embryos/animals
obtained at each specific developmental stage from HdhneoQ20/+ x Hdhex4/5/+ crosses. Data are related to Fig 1.
WT HdhneoQ20/+ Hdhex4/5/+ HdhneoQ20/Hdhex4/5
Age
(d.p.c)
Total number
(Litters)
Normal
(%)
Abnormal
(%)
Normal
(%)
Abnormal
(%)
Normal
(%)
Abnormal
(%)
Normal
(%)
Abnormal
(%)
P0 Birth 13
(1)
5/5
(100)
0/5
(0)
3/3
(100)
0/0
(0)
4/4
(100)
0/4
(0)
0/1
(0)
1/1
(100)�
E18.5 82
(6)
17/17
(100)
0/17
(0)
23/23
(100)
0/23
(0)
20/20
(100)
0/20
(0)
0/22
(0)
22/22
(100)��
E14.5 13
(1)
5/5
(100)
0/5
(0)
2/2
(100)
0/2
(0)
3/3
(100)
0/3
(0)
3/3
(100)
0/3
(0)
E11.5 22
(2)
8/8
(100)
0 /8
(0)
8/8
(100)
0/8
(0)
4/4
(100)
0/4
(0)
2/2
(100)
0/2
(0)
�1 small with mild dome head
��17 small with mild dome head, 1 aborted, 4 resorbed
https://doi.org/10.1371/journal.pgen.1007765.t001
Table 2. Related to Fig 1 phenotypes. The table summarizes the total number of animals per litter and the percentages of normal and abnormal embryos/animals
obtained at each specific developmental stage from HdhneoQ50/+ x Hdhex4/5/+ crosses. Data are related to Fig 1.
WT HdhneoQ50/+ Hdhex4/5/+ HdhneoQ50/Hdhex4/5
Age
(d.p.c)
Total number
(Litters)
Normal
(%)
Abnormal
(%)
Normal
(%)
Abnormal
(%)
Normal
(%)
Abnormal
(%)
Normal
(%)
Abnormal
(%)
P0 Birth 16
(2)
3/3
(100)
0/3
(0)
10/10
(100)
0/10
(0)
3/3
(100)
0/3
(0)
0/0
(0)
0/0
(0)
E18.5 267
(20)
81/81
(100)
0/81
(0)
71/71
(100)
0/71
(0)
56/56
(100)
0/56
(0)
0/59
(0)
59/59
(100)�
E14.5/ E15.5 32
(3)
6/6
(100)
0/6
(0)
11/11
(100)
0/11
(0)
6/6
(100)
0/6
(0)
0/9
(0)
9/9
(100)��
E12.5/ E13 25
(2)
8/8
(100)
0/8
(0)
6/6
(100)
0/6
(0)
4/4
(100)
0/4
(0)
0/7
(0)
7/7
(100)���
E10.5/ E11 24
(2)
6/6
(100)
0/6
(0)
7/7
(100)
0/7
(0)
5/5
(100)
0/5
(0)
0/7
(0)
6/6
(100)���
�31 small with dome head, 5 small with exencephaly, 14 aborted, 9 resorbed
��6 dome head, 3 resorbed
���all small
https://doi.org/10.1371/journal.pgen.1007765.t002
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occasionally lack of the structure, while 33% of HdhneoQ20/Hdhex4/5 had (unilateral) hypoplas-
tic pinna (Fig 3A and 3B, Table 5). Impact on middle ear structures further distinguished the
inactivating alleles. Whereas all HdhneoQ20/Hdhex4/5 embryos had middle ear components,
75% of HdhneoQ50/Hdhex4/5 embryos lacked the tympanic ring, gonium, malleus, incus, and
the third ossicle stapes, although Meckel’s cartilage was intact (Fig 3C, Table 5). The squamous
bone was hypoplastic (Fig 3D, Table 5). For both inactivating mutations, inner ear structures
were normal. At E10.5, Gsc and Hoxa2 expression in HdhneoQ50/Hdhex4/5 embryos was abnor-
mal. Gsc mRNA, detected in the first and second branchial arches in wild-type embryos, was
restricted to the first branchial arch. Hoxa2 mRNA was reduced in intensity at the level of the
branchial arches although intense staining was detected dorsally, suggesting a delayed or
impaired migration of the neural-crest derived cells to colonize the arches, thereby possibly
affecting the proper formation of ear structures (Fig 3E and 3F).
Skin barrier
E18.5 HdhneoQ20/Hdhex4/5 embryos, like embryos with a wild-type allele, excluded toluidine
blue dye, demonstrating proper formation of the cornified layer that serves as the skin barrier,
but 100% of the HdhneoQ50/Hdhex4/5 hypomorphs excluded dye from the dorsal, but not the
ventral epidermis (Fig 4A). The four stratified layers of the epidermis (basal, spinous, granular,
cornified) were present. However, immunoblot analysis indicated significant decreased levels
of mature filaggrin (27 kDa, epidermal granular layer marker [19]) and profilaggrin processing
intermediates (50–70 kDa), while loricrin (epidermal cornified layer marker) remained mostly
unchanged (Fig 4B and 4C). HdhneoQ50/Hdhex4/5 ventral epidermis also exhibited decreased
(88% reduction compared to wild-type) PCNA staining (S-phase cell cycle marker) and
increased TdT-mediated dUTP nick-end labeling (TUNEL)-positive apoptotic cells, compared
to wild-type (Fig 4C and 4D), consistent with failed differentiation.
Hematopoiesis
At E14.5, HdhneoQ20/Hdhex4/5 embryos were unremarkable but HdhneoQ50/Hdhex4/5 embryos
had small, pale livers, as well as abnormal vasculature and extensive blood inclusions in the
head (brain and ventricles) reported previously [9] (Fig 5A, S1 Fig). Flow cytometry (FACS) of
Table 3. Related to Fig 1 phenotypes. The table summarizes the total number of animals per litter and the percentages of normal and abnormal embryos/animals
obtained at each specific developmental stage from HdhneoQ111/+ x Hdhex4/5/+ crosses. Data are related to Fig 1.
WT HdhneoQ111/+ Hdhex4/5/+ HdhneoQ111/Hdhex4/5
Age
(d.p.c)
Total number
(Litters)
Normal
(%)
Abnormal
(%)
Normal
(%)
Abnormal
(%)
Normal
(%)
Abnormal
(%)
Normal
(%)
Abnormal
(%)
E18.5 30
(3)
8/8
(100)
0/8
(0)
9/9
(100)
0/9
(0)
13/13
(100)
0/13
(0)
0/0
(0)
0/0
(0)
E14.5 13
(1)
4/4
(100)
0/4
(0)
3/3
(100)
0/3
(0)
2/2
(100)
0/2
(0)
0/4
(0)
4/4
(100)�
E10.5 10
(1)
5/5
(100)
0/5
(0)
4/4
(100)
0/4
(0)
1/1
(100)
0/1
(0)
0/0
(0)
0/0
(0)
E9 12
(1)
4/4
(100)
0/4
(0)
1/1
(100)
0/1
(0)
4/4
(100)
0/4
(0)
0/3
(0)
3/3
(100)��
E8.5 37
(3)
12/12
(100)
0/12
(0)
7/7
(100)
0/7
(0)
5/5
(100)
0/5
(0)
0/13
(0)
13/13
(100)��
� resorbed
��delayed sock-like embryonic portion
https://doi.org/10.1371/journal.pgen.1007765.t003
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fetal liver cells showed decreased absolute cell number and lack of erythropoiesis (CD71hi-
Ter119neg-lo proerythroblasts to CD71hiTer119+ basophilic erythroblasts to CD71+Ter119+
polychromatic erythroblasts to CD71–Ter119+ reticulocytes) in HdhneoQ50/Hdhex4/5 embryos
(Fig 5B and 5C), concomitant with increased numbers of myeloid (Mac-1+Gr-1–) and B cell
progenitors (B220+CD19–) (Fig 5B and 5C). Furthermore, the numbers of erythroid (CFU-E)
and megakaryocyte (CFU-Mk) colony forming progenitors were decreased, along with a
decrease in the total number of colony forming cells (Fig 5D), implying impaired expansion of
HSCs/progenitor cells and defective erythropoiesis. The impairment was transient, as E18.5
HdhneoQ50/Hdhex4/5 livers did not show these hematopoietic deficits (Fig 5E–5I). Analysis of
thymus at this age also did not reveal deficits in the development of CD4+CD8+ double positive
T cells suggesting normal T- lymphopoiesis, despite an apparently decreased number of thy-
mic precursors (Fig 5E–5I).
Hdhex4/5/ex4/5 developmental response to retinoic acid-induced
differentiation
In comparisons of wild-type and Hdhex4/5/ex4/5 null embryonic stem cells (ESC), at baseline
and after Embryoid body (EB) retinoic acid (RA)-induced differentiation, we have found pre-
viously that complete Htt inactivation impairs PRC2 activity [12,13] and alters genome-wide
deposition of epigenetic chromatin marks [12,13]. Since RA-differentiation of ESC provides a
culture system with which to study not only neurogenesis but also organogenesis [20–22]
more broadly, we utilized this paradigm to identify transcriptional regulators responsive to Htt
dosage that may play a role in the incomplete hypomorph rescue of the Hdhex4/5/ex4/5 null
allele. Specifically, we performed differential gene expression analyses of genome-wide RNA
and miRNA next generation sequencing data (S1 Table) generated from wild-type parental
ESC, Hdhex4/5/ex4/5 ESC and from wild-type and Hdhex4/5/ex4/5 EB differentiated cells, treated
with RA. The overall gene expression changes, upon RA-induced differentiation, were quanti-
tatively and qualitatively similar for wild-type and Hdhex4/5/ex4/5 cells: 79% of the several hun-
dred changed RA-responsive miRNAs were shared (S2 Fig, S1 File) and 86% of the more than
9,000 mRNA gene expression changes were shared (S2 Fig, S1 File). Functional annotation
enrichment analysis (clusterProfiler) [23] highlighted genes involved in organogenesis in a
large differentiation up-regulated cluster (Cluster 1, S2 Fig), associated with terms such as
Skeleton, Ossification, Ear, Skin and Neuron development (S2 Fig, S2 File), as well as genes
involved in subcellular processes in a smaller down-regulated class (Cluster 2) (S2E Fig), with
enriched terms such as DNA metabolic process, Ribosome biogenesis, Cell Cycle (S2 Fig, S2
Fig 1. HdhneoQ20/Hdhex4/5, HdhneoQ50/Hdhex4/5 and HdhneoQ111/Hdhex4/5 hypomorphic embryos. A) Representative
pictures of wild-type (WT), Hdhex4/5/+, HdhneoQ20/+, HdhneoQ50/+, HdhneoQ111/+, HdhneoQ20/Hdhex4/5, HdhneoQ50/
Hdhex4/5 and HdhneoQ111/Hdhex4/5 embryos. The size and the shape of embryos with different genotypes is shown at
E18.5 for animals generated by crossing HdhneoQ20/+ with Hdhex4/5/+ mice and HdhneoQ50/+ with Hdhex4/5/+ mice. For
embryos generated by crossing HdhneoQ111/+ with Hdhex4/5/+ mice, representative pictures were taken at E 8.5. Dashed
white line in the WT image outlines the rostral part of the forebrain headfolds and the white arrow points to the heart.
The yellow dashed lines in the HdhneoQ111/Hdhex4/5 images depict anterior endoderm in the late stage streak embryo,
typical of a mouse developmental stage of E7.5. Scale bar = 300μm. Tables 1–3 summarizes the appearances of all
embryos analyzed and the penetrance of the phenotypes. B-C) Box-and-whisker graphs show quartiles of height in cm
(cm) and weight in grams (g) of different genotypic groups of animals generated by crossing HdhneoQ20/+ with Hdhex4/5/+
mice. The median is indicated and whiskers indicate 1.5XIQR. The number (N) of animals for each group is indicated
above. Error bars represent standard deviations from the mean. D-E) Box-and-whisker graphs show quartiles of height in
cm (cm) and weight in grams (g) of different genotypic groups of animals generated by crossing HdhneoQ50/+ with
Hdhex4/5/+ mice. The median is indicated and whiskers indicate 1.5XIQR. The number (N) of animals for each group is
indicated above. A significant reduction in size of HdhneoQ50/Hdhex4/5 embryos is noted. P value< 0.05 (�). Error bars
represent standard deviations from the mean.
https://doi.org/10.1371/journal.pgen.1007765.g001
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File). We then determined the impact of Htt nullizigosity on development, assessing the initial
pluripotent stage (wild-type versus Hdhex4/5/ex4/5 ESC) as well as the differentiated stage (wild-
type versus Hdhex4/5/ex4/5 RA-induced) (S3 Fig, S1 File). The results disclosed a modest number
of miRNAs (ESC: 149 up: 95 down; RA: 70 up; 86 down) and mRNAs (ESC: 699 up: 461 down;
RA 1314 up; 1784 down), whose expression was sensitive to Htt inactivation. These were
largely specific to a given developmental stage (S3 Fig, S1 File), forming four non-overlapping
gene sets (ESC-up, ESC-down, RA-up and RA-down) (S3 Fig, S2 File). Gene Ontology and
pathway enrichment analysis revealed highly significant enrichment of the Htt-inactivation
sensitive RA-down gene set in developmental pathways related to organ system deficits
observed in the hypomorphic mice: ‘skeletal system development’, ‘generation of neurons’,
‘blood vessel morphogenesis’, ‘blood vessel morphogenesis’, ‘skin development’ and ‘ear devel-
opment’ (S3 Fig).
Fig 2. Skeletal defects in HdhneoQ20/Hdhex4/5 and HdhneoQ50/Hdhex4/5 hypomorphic embryos. Representative
images of alcian blue and alizarin red-stained skeletal preparations from wild-type (WT), HdhneoQ20/Hdhex4/5, and
HdhneoQ50/Hdhex4/5 E 18.5 embryos. A) Lumbar to sacral transformations (L6 to S1) in HdhneoQ20/Hdhex4/5 and
HdhneoQ50/Hdhex4/5 embryos, where sacral area with the iliac bones is enlarged in the inset, L1 to L6 indicate lumbar
vertebrae, T13 is the 13th thoracic vertebra and skeletal transformation is in red text. B) Defects in the sternum and
xyphoid process of HdhneoQ20/Hdhex4/5, HdhneoQ50/Hdhex4/5 mice, enlarged in the insets, showing xyphoid process
fenestration in HdhneoQ20/Hdhex4/5 embryos, with thoracic ribs numbered (black text). C-D) Cervical vertebrae defects
in HdhneoQ20/Hdhex4/5 and HdhneoQ50/Hdhex4/5 animals, with the latter having an increase in the gap between C1 and
C2 vertebrae, seen in horizontal (C) and vertical side (D) views. E) Defects in the morphology [greater horns (�)] and
spacing between hyoid bone and cartilage structures, evident in the HdhneoQ50/Hdhex4/5 embryos. Scale bars in (A) and
(B) = 1mm; scale bars in (C), (D), (E) = 500μm. See Table 4 for detailed description of the litters and quantitative
analysis of the phenotypes.
https://doi.org/10.1371/journal.pgen.1007765.g002
Table 4. Related to Fig 2 Skeletal Phenotypes. The table summarizes the total number and the percentages of abnormal embryos presenting skeletal abnormalities (L6 to
S1 transformation, Inverted Sternum tip, Six Vertebrosternal ribs, Fenestrated xiphoid process, T13 Aborted ribs, C1 to C2 gap, C1 to C2, C7 to T1, Hyoid defect) obtained
for each genotype. Data are related to Fig 2.
Skeletal abnormalities WT
Abnormal
(%)
Hdhex4/5/+
Abnormal
(%)
HdhneoQ20/+
Abnormal
(%)
HdhneoQ20/Hdhex4/5
Abnormal
(%)
HdhneoQ50/+
Abnormal
(%)
HdhneoQ50/Hdhex4/5
Abnormal
(%)
L6 to S1 0/8
(0)
0/8
(0)
0/6
(0)
1/6�
(16.6)
0/6
(0)
2/8��
(25)
Inverted Sternum tip 0/8
(0)
0/8
(0)
0/6
(0)
3/6
(50)
0/6
(0)
5/8
(62.5)
Six Vertebrosternal ribs 0/8
(0)
0/8
(0)
0/6
(0)
0/6
(0)
0/6
(0)
0/8
(0)
Fenestrated xiphoid process 0/8
(0)
0/8
(0)
0/6
(0)
4/6
(66.6)
0/6
(0)
0/8
(0)
T13 Aborted ribs 0/8
(0)
0/8
(0)
0/6
(0)
0/6
(0)
0/6
(0)
0/8
(0)
C1 to C2 gap 0/8
(0)
0/8
(0)
0/6
(0)
0/6
(0)
0/6
(0)
8/8
(100)
C1 to C2 0/8
(0)
0/8
(0)
0/6
(0)
0/6
(0)
0/6
(0)
0/8
(0)
C7 to T1 0/8
(0)
0/8
(0)
0/6
(0)
0/6
(0)
0/6
(0)
0/8
(0)
Hyoid defect 0/8
(0)
0/8
(0)
0/6
(0)
1/6
(16.6)
0/6
(0)
5/8
(62.5)
� Unilateral
�� Bilateral phenotypes.
https://doi.org/10.1371/journal.pgen.1007765.t004
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In addition, we examined the interplay between RA-differentiation and Htt-inactivation,
generating four gene expression sets: up_up, up_down, down_up and down_down, depending
upon whether expression of a particular gene or miRNA was significantly up- or down-regu-
lated by RA-differentiation and further was up- or down-regulated by Hdhex4/5/Hdhex4/5 null
mutation, respectively (Fig 6A and 6B, S1 File). Interestingly, miRNAs were evenly distributed
across these classes (S1 File), while the mRNA expression changes were largely in the up_down
class (Fig 6C). With these RA-differentiation-Htt-null gene sets we performed pathways analy-
ses to assess membership in: 1) available Gene Ontology biological processes, 2) manually
curated lists of genes relevant to organ development found to be abnormal in hypomorphic
mice (Materials and Methods, S2 Table and S1 and S3 Files) lists of genes expressed in specific
brain cell types (210 neuron genes, 144 astrocyte genes, 61 oligodendrocyte genes [24], specifi-
cally to assess the hypothesis that Htt null mutation alters the neuron-glia developmental
switch [25–27]. The results of Gene Ontology analysis showed significant enrichment, mostly
for ‘up_down but also the ‘up_up gene sets, highly associated with the terms ‘Organ Morpho-
genesis’, ‘Nervous System Development’, ‘Skeletal System Morphogenesis’, ‘Blood Vessel Mor-
phogenesis’, ‘Ear Development’ and ‘Skin Development’ (Fig 6D, S2 File). Analysis with our
manually-curated lists of genes involved in body weight (bodyweight), skin differentiation
(skin), skeleton development (skeleton), middle-ear development (middle-ear) and hemato-
poiesis revealed significant enrichment scores for all of these hypomorph phenotype-related
Fig 3. External and middle ear defects in HdhneoQ20/Hdhex4/5 and HdhneoQ50/Hdhex4/5 hypomorphic embryos. A)
Representative images of wild-type (WT), HdhneoQ20/Hdhex4/5 and HdhneoQ50/Hdhex4/5 heads, showing altered morphology of
external ear in HdhneoQ20/Hdhex4/5 and HdhneoQ50/Hdhex4/5 animals at E18.5. B) The region of the external ear is enlarged
from (A) for each genotype, showing mis-shapen or missing external ears for the HdhneoQ20/Hdhex4/5 and HdhneoQ50/Hdhex4/5
animals. C) Representative images of alcian blue and alizarin red-stained middle ear preparations from wild-type (WT),
HdhneoQ20/Hdhex4/5 and HdhneoQ50/Hdhex4/5 E18.5 embryos, showing severely altered middle ossicles in HdhneoQ50/Hdhex4/5
animals. Middle ear ossicles are indicated in the WT preparation: M = manubrium, PB = processus brevis. In HdhneoQ50/
Hdhex4/5 animals, all the middle ear ossicles were absent, only the Meckel’s Cartilage (MC) was observed. D) Representative
images of alcian blue and alizarin red-stained middle ear preparations from wild-type (WT), HdhneoQ20/Hdhex4/5 and
HdhneoQ50/Hdhex4/5 E18.5 animals, showing hypoplastic squamous bone (SQ_B) in HdhneoQ20/Hdhex4/5 and HdhneoQ50/
Hdhex4/5 animals. Black line delineates the squamosal bone. E) Whole mount in situ hybridization representative images
showing altered Gsc mRNA localization in HdhneoQ50/Hdhex4/5 embryos at E11.5. The inset shows an enlarged view of the
pharyngeal arches with Gsc transcript staining localized in the I-md and II arch in WT, but only localized in the first arch in
HdhneoQ50/Hdhex4/5 embryos. Abbreviations: I-md = mandibular process of pharyngeal arch 1; I-mx = maxillary process of
pharyngeal arch 1; II = pharyngeal arch 2. Dashed lines delineate pharyngeal arches. F) Whole mount in situ hybridization
representative images showing altered Hoxa2 mRNA localization in HdhneoQ50/Hdhex4/5 embryos at E11.5. The arrows
indicate ectopic expression of Hoxa2 transcript in the dorsal area of HdhneoQ50/Hdhex4/5 embryos. Scale bars, 1.5 mm for A-B;
400 μm for C-D; 1.5 mm for E-F.
https://doi.org/10.1371/journal.pgen.1007765.g003
Table 5. Related to Fig 3 Ear Phenotypes. The table summarizes the penetrance (percentages of abnormal embryos) of ear phenotypes (Hypoplastic External Ear, Loss of
Middle Ear Structures, Hypoplastic Squamosal bone) obtained for each genotype. Data are related to Fig 3.
Penetrance
of ear abnormalities
WT
Abnormal
(%)
Hdhex4/5/+
Abnormal
(%)
HdhneoQ20/+
Abnormal
(%)
HdhneoQ20/Hdhex4/5
Abnormal
(%)
HdhneoQ50/+
Abnormal
(%)
HdhneoQ50/Hdhex4/5
Abnormal
(%)
Hypoplastic External Ear 0/8
(0)
0/8
(0)
0/6
(0)
2/6�
(33.3)
0/6
(0)
8/8��
(100)
Loss of Middle Ear Structures 0/8
(0)
0/8
(0)
0/6
(0)
0/6
(0)
0/6
(0)
6/8��
(75)
Hypoplastic Squamosal bone 0/8
(0)
0/8
(0)
0/6
(0)
0/6
(0)
0/6
(0)
8/8��
(100)
� Unilateral
�� Bilateral phenotypes.
https://doi.org/10.1371/journal.pgen.1007765.t005
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pathways, with the majority of the genes belonging to the ‘up-down’ class being up-regulated
by RA-differentiation and down-regulated by Htt null mutation (Fig 7A–7C). Furthermore,
this class also contained most of the differentially regulated astrocyte and oligodendrocyte spe-
cific genes, whereas most of the neuron-specific genes were in the up-up class, up-regulated by
RA differentiation and further up-regulated by Htt null mutation (S4 Fig, S1 File). This differ-
ential impact on genes expressed in neurons and in the major macroglial cell types strongly
implied an effect on neurogenesis that, by analogy, implied effects of Htt loss of function muta-
tion on progenitor stem cells.
Integrative regulatory network analysis
Differentiation reflects the coordinated action of epigenetic regulators, transcription factors
and post-transcriptional events among which those regulated by miRNAs on gene expression.
Therefore, to determine whether Htt inactivation may influence regulatory loops, thereby
affecting the expression of downstream targets that may be involved in hypomophic mutation-
associated mouse developmental phenotypes, we performed analysis with the above men-
tioned RA-differentiation-Htt-null gene sets to evaluate: 1) enrichment of targets of chromatin
regulators in the ChEA experimental ChIP-seq database [28] and 2) potential miRNA regula-
tors, by virtue of having a differentiation-Htt null expression pattern (down-down and down-
up) that was opposite to that of their mRNA target genes (up-up and up-down) [29,30]. Con-
sistent with previous reports, the results of the chromatin regulator analysis revealed a strong
enrichment for targets of polycomb regulators (Fig 8A) among the differentiation genes also
regulated by Htt inactivating mutation, especially members of the PRC2 complex (S3 File).
The second analysis revealed a set of 22 RA-differentiation-Htt-null responsive miRNAs
whose known target genes’ expression pattern fulfilled our criteria (S1 File) (Fig 8B and 8C, S4
File), with let-7b-5p and miR-329-3p the most significant for the down-down and down-up
expression pattern classes, respectively. A functional enrichment analysis of the mRNAs regu-
lated by our list of 22 miRNAs whose expression pattern fit our criteria (opposite to that of the
binding miRNAs) confirmed enrichment of ‘up-up’ miRNA target genes in processes involved
in ‘nervous system development, ‘axonogenesis’ and ‘synapse’, while the targets of ‘up-down’
miRNAs were enriched for terms related to ‘skeletal system development’, ‘organ morphogen-
esis’, ‘vasculature development’ ‘ear development’ and ‘skin development’ (Fig 8B and 8C),
implying a role for these regulators and target genes in the altered developmental phenotypes
observed in mice with expression of the HD gene orthologue below a single functional allele.
Discussion
HD is a dominantly inherited neurodegenerative disorder for which there is as yet no disease-
modifying intervention. It is hoped that approaches that decrease expression of the mutant
Fig 4. Skin defects in HdhneoQ50/Hdhex4/5 hypomorphic embryos. Representative images of wild-type (WT) and HdhneoQ50/
Hdhex4/5 animals, at E18.5. A) At E18.5, following toluidine-blue dye exclusion assay, WT animal shows a functional
epidermal barrier but HdhneoQ50/Hdhex4/5 animal has a compromised epidermal barrier on the ventral surface. B)
Immunoblot analyses of WT, Hdhex4/5/+, HdhneoQ50/+ and HdhneoQ50/Hdhex4/5 skin protein extracts (E18.5). Bands of Pro-
filaggrin (pro-Flg, 2X-Flg, 3X-Flg) at 50–70 KDa and higher molecular weight bands and processed filaggrin (Flg) at 27 KDa
were detected in all samples but were decreased in HdhneoQ50/Hdhex4/5 extracts. The bands of Loricrin (Lor) and alpha-tubulin
(Tuba1) were similar in all samples. C) Bar graphs summarizing skin-extract protein immunoblot band signal-intensity
(relative to WT), expressed as standard deviation of 3 biologic replicates using 2 mice each, as quantified by Image J software.
Unpaired t-test. P value< 0.05 (�), P< 0.0001 (���). D) Representative images of cryostat-sectioned skin tissue, with DAPI
stained nuclei to show reduced staining of the PCNA proliferation marker in HdhneoQ50/Hdhex4/5 skin. Green = PCNA
staining; Blue = DAPI-stained nuclei. Dashed lines depict the cornified basal epidermal layer. All images were taken using a
fluorescent 20X objective. Scale bars: 50μm E) Representative images of cryostat-sectioned skin tissue stained with TUNEL
assay to quantify apoptotic cell death (arrows) in WT and HdhneoQ50/Hdhex4/5 embryos. Dashed lines depict the cornified
basal epidermal layer. All images were taken using a phase-contrast 20X objective. Scale bars: 50μm.
https://doi.org/10.1371/journal.pgen.1007765.g004
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Fig 5. Hematopoietic defects in HdhneoQ50/Hdhex4/5 hypomorphic embryos. A, E) Representative images of the appearance of fetal liver in wild-type (WT)
and HdhneoQ50/Hdhex4/5 embryos displaying dome shaped cranium and exencephaly at E14.5 and E18.5. Scale bars: 1 mm. B, F, G) Representative FACS
profiles of fetal liver hematopoiesis in wild-type (WT) and HdhneoQ50/Hdhex4/5 embryos at E14.5 and E18.5, respectively. Erythroblasts were gated into fractions
defined by CD71 and Ter119 expression, displaying transient anemia at E14.5, rescued by E18.5. Myeloid cells and B cell progenitors were identified as Mac-
1+Gr-1– and B220+CD19–, respectively at E14.5 fetal liver T cells were stained with CD4 and CD8a cell surface markers. C, H) Bar graphs summarizing the
absolute cell numbers of whole fetal liver at E14.5 and E18.5 for wild-type (WT) and HdhneoQ50/Hdhex4/5 embryos, displaying transient defects in hematopoiesis
at E14.5. At E14.5, WT embryos N = 5, HdhneoQ50/Hdhex4/5 embryos N = 3. At E18.5, WT embryos N = 3, HdhneoQ50/Hdhex4/5 embryos N = 3. Error bars
represent standard deviations from the mean. (��) and (�) indicate significant P value, with (��) P<0.01 and (�) P<0.05, respectively. D, I) Bar graphs
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gene, or both the mutant and normal gene, will provide benefit as suggested by observations
from pre-clinical studies in model systems [31,32]. However, there is a need to better under-
stand HTT function, in order to forecast potential effects of HTT silencing and lowering
summarizing the results of colony assays on wild-type (WT) and HdhneoQ50/Hdhex4/5 fetal liver indicate a dramatic depletion of erythroid (CFU-E),
Megakaryocytes (CFU-Mk) and total colony forming cells (Total CFCs) in E14.5 HdhneoQ50/Hdhex4/5 fetal liver. By E 18.5, the phenotype was completely
rescued and no difference in erythroid (CFU-E and BFU-E (E)), megakaryocyte (CFU-Mk) myeloid (G, M, GM), erythroid-megakaryocyte (E/Mk) and multi-
lineage mixed (Mix) colony forming cells was observed. Error bars represent standard deviations from the mean. d3, day3; d5, day5, d12, day12.
https://doi.org/10.1371/journal.pgen.1007765.g005
Fig 6. Classes of genes implicated in organ development whose expression was altered by Httex4/5 null mutation. A) Schematic describing the criteria
applied to define the 4 classes of genes sensitive to both Hdhex4/5 null mutation and RA-induced differentiation. Up_up: genes up-regulated during
differentiation and up-regulated by the Htt-null mutation; up_down: genes up-regulated during differentiation but down-regulated by Htt-null mutation;
down_down: genes down-regulated during differentiation and further down-regulated by Htt-null mutation; down_up: genes down-regulated during
differentiation, but upregulated in the context of Htt-null mutation. B) Expression trajectory plots describing variations in transcriptional levels across the two
Htt genotypes (WT and dKO) and two developmental stages (ESC and RA-DIFF) of the genes belonging to the 4 categories described in A). a.u., arbitrary
units. C) Bar blots displaying the number of genes (from RNA-seq analysis) for each of the 4 categories (up_up, up_down, down_down, down_up as described
in A). Most of the genes were found in the up_up and up_down groupings. D) Enrichment analysis of genes belonging to the 4 categories (Up_up; up_down;
down_up; down_down, as described in A), highlighting the most enriched GO-terms [BP, Biological Process; CC, Cellular Component; MF; Molecular
Function; KEGGs pathways and Reactome pathways]. Significance of enrichment is based on FDR values [color code as in the legend].
https://doi.org/10.1371/journal.pgen.1007765.g006
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strategies and also, as HTT loss of function mutation may reveal HTT-mediated biological pro-
cesses, to understand precisely how HTT CAG expansion mutation may harm vulnerable cell
populations that drive the features of the disease.
Fig 7. Httex4/5 null mutation, in the context of RA-differentiation, significantly perturbed genes implicated in ‘body weight’, ‘skin, skeleton, middle-ear
development’ and ‘hematopoiesis’. A) Venn diagram representation of the intersection of genes relevant to Htt hypmorph phenotypes (bodyweight, skin, skeleton,
middle ear and hematopoiesis) and genes whose expression changes with Htt-genotype in stem cells (ESC) and during RA-EB differentiation (RA-DIFF). The genes in this
intersection were analyzed further in B) and C). B) The number of intersection genes associated with each of the Htt hypomorph relevant phenotypes C) Expression
trajectory plots (upper row) and enrichment analysis (lower row) of the four classes of genes (up-up; up-down; down-up; down-down; Fig 6) in the intersection with
developmental genes associated with Htt hypmorph related phenotypes.
https://doi.org/10.1371/journal.pgen.1007765.g007
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Our genetic assessment of dosage effects, in which different hypomorphic mutations of the
mouse HD gene orthologue attempt to rescue a null allele, has revealed critical involvement of
Htt throughout development, from conception. The increasingly severe recessive developmen-
tal impact of the HdhneoQ20, HdhneoQ50, and HdhneoQ111 hypomorphic allelic series was consis-
tent with the previously reported increasingly severe impact of each of these mutant alleles on
decreasing huntingtin expression, as judged by immunoblot analysis of heterozygotes. Hun-
tingtin from a single HdhneoQ50 allele in ES cells was approximately 8–10% of the level of a sin-
gle wild-type allele [9]. In brain the level of huntingtin from a single milder HdhneoQ20 allele
was about 15–20% of a single wild-type allele, while the huntingtin from a single severe
HdhneoQ111 allele was barely detected and estimated to be less than 1–5% of the wild-type allele
[9,18]. Indeed, the severe HdhneoQ111 mutation, similar to homozygote null alleles, was charac-
terized by a huntingtin level insufficient to properly initiate the organogenesis phase causing
embryos to fail post-gastrulation, before head-folds become evident. Second, the intermediate
severe HdhneoQ50 mutation, did make sufficient huntingtin to overcome this first block, but
this level was insufficient later, such that embryos failed after E10.5–12.5 [18], with survivors
revealing several needful organ systems: brain, skeleton, middle and external ear, and skin bar-
rier acquisition and fetal liver erythropoiesis. Third, the dose of huntingtin from the milder
severe HdhneoQ20 mutation was also wanting but was sufficient for preventing most deficits
observed with more severe mutations. Exceptions included the low penetrant external ear and
sternum deficits and the enlarged ventricles, neurological and skeletal muscle alterations and
white matter abnormalities noted previously [9,17,18] along with developmental delay after
E14.5. These small mice are born and can be viable (and are fertile) with assistance in the form
of removal of normal littermates (with a wild-type allele) or hand-rearing [18]. These findings,
taken together with previous observations that the cognate (neo-out) HdhQ20, Hdh50, HdhQ111
CAG repeat knock-in alleles (appropriately expressing endogenous mutant huntingtin with 20-,
50- and 111-glutamines) fully rescue the Hdhex4/5 null [9,33] clearly demonstrate that the equiv-
alent of a single functional HD orthologue allele (regardless of CAG repeat size) fully supports
proper development. The null rescue paradigm and observations with the HdhneoQ20,
HdhneoQ50, and HdhneoQ111 hypomorphic alleles now provide sequential temporal developmen-
tal windows that can be investigated using high resolution protein detection methods to deter-
mine the precise levels of huntingtin that may be required to support the proper development
of a given tissue. Our findings complement and enrich previous observations of aberrant exter-
nal ear, vasculature, brain development and neurological deficits in mice that are compound
heterozygote for neo-in hypomorphic alleles [17,18] and are also consistent with the report of a
family segregating two HTT inactivating mutations, where compound heterozygotes exhibit
decreased survival, global developmental delay and neurological deficits [15,16]. Indeed, our
results strongly suggest that the HTT [c.4469+1G>A] andHTT [c.8156T>A] mutations segre-
gating in this family are functionally hypomorphic rather than completely inactivating.
Our molecular analysis of wild-type ESC and ESC with the Hdhex4/5 null mutation, in a RA-
morphogen-driven-paradigm [20–22], which we confirmed elicits broad effects on develop-
mental genes, has nominated categories of regulators sensitive to huntingtin dosage that seem
likely to play key roles in Htt function during organ system development. One important cate-
gory is polycomb group proteins: PRC2 (Suz12, Eed, Jarid2 and Mtf2), implicated previously
[12,13], as well as PRC1 (Bmi1, Ring1b), which are especially relevant for neurogenesis, hema-
topoiesis, skeleton and middle-ear formation [34–38]. The other major category is a group of
miRNAs, among which Let-7b-5p and miR-129-3p, with known involvement in nervous sys-
tem development, as well as skeletal, ear and skin development [39–41]. Precisely which pro-
cesses these potential regulators orchestrate and how they may be disrupted by the lack of
functional Htt in different organ systems remains to be investigated. However, several
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observations in severely hypomorphic embryos at different ages strongly suggest an impact at
the level of progenitor stem cells implicating effectors of these regulators that are critical to cell
adhesion or other aspects of cell-migration and can thereby influence lineage fate: 1) the pha-
ryngeal arches were formed but the middle-ear fated Gsc-positive cells were located in the first
arch, rather than in the second and third arches, implying delayed migration of these progeni-
tor cells [42,43]; 2) ventral skin barrier formation was not permanently disrupted, only delayed
at E18.5, suggesting aberrantly slow migration of epidermal precursors with delayed formation
of a cornified layer and acquisition of barrier [44,45]; and 3) deficits in fetal liver hematopoiesis
were transient, resolved by E18.5, consistent with delayed migration from the blood islands in
the yolk sac, the site of embryonic hematopoiesis [46]. In addition, as reported previously in a
variety of other experimental systems [9,12,18,25–27,47], neurogenesis and brain development
is abnormal in the absence of sufficient Htt. The results of our gene expression analysis, in the
retinoic acid-EB-differentiation paradigm, support disruption of a process at the level of neural
progenitor cells that influences the proportion of daughter neuronal and macroglial cell types,
a process that normally involves the acquisition by radial glia of adherens junctions important
for cell migration and proper specification, initially of neurons and later of astrocytes and oli-
godendrocytes [48]. This conclusion appears to differ from conclusions drawn previously
from studies that employ other differentiation paradigms, for example in Nguyen, 2013 [25] in
vivo and in Conforti, 2013 in ES cell rosette protocol [27], suggesting that the precise role of
huntingtin in neurogenesis may depend upon the exact subtypes of progenitor cells that are
specified, an area that warrants further investigation.
It is evident that the inherited CAG repeat expansion mutation does not recapitulate the
blatant effects produced by inheritance of two HTT inactivating mutations. HD mutation car-
riers, even homozygotes, are overtly indistinguishable from those who do not carry the muta-
tion, until subtle changes presage the emergence of signs of the neurodegenerative disorder
[49,50]. By contrast, though one active allele is sufficient [9], levels below a single allele’s worth
of HTT function produce developmental consequences that our findings show can vary dra-
matically in scope and severity with dosage. Studies of decreased Htt dosage later in develop-
ment in adults, rather than at conception, are more equivocal. Some reports show harmful
consequences from neuron-specific knock-out, for example in [51], while a different strategy
did not elicit harmful effects [52]. Our findings suggest that, if the harmful effects of the HD
mutation are due to some opportunity for mischief that is provided by normal HTT function,
then studies of the polycomb group protein genes and Let-7b-5p and miR-129-3p miRNAs as
regulators of cellular adhesion may illuminate the biology that is disrupted by the HD muta-
tion and, thereby, provide specific assays with which to evaluate therapeutics that aim to
decrease or silence expression of the gene in individuals with the HD mutation.
Methods
Ethics statements
All the mouse experiments were conducted in accordance with an IACUC approved protocol,
through the MGH Subcommittee on Animal Research.
Fig 8. Regulatory network analysis highlights Polycomb group protein and miRNAs as possible regulators. A) Enrichment analysis of genes whose
expression is changed by Hdhex4/5/ex4/5 null, that are involved in developmental phenotypes and regulated by Polycomb group proteins, based on ChEA
ChIP-Seq annotation. Significance of enrichment is based on FDR values [color code as in the legend]. B) List of 22 miRNAs whose expression is altered by
RA-differentiation and by Hdhex4/5 null genotype, but whose change in expression is significantly anti-correlated relative to expression change observed in
the miRNA target genes. miRNAs identified by these criteria are by definition either down-down or down-up. miRNAs are ranked according to the p-
value associated with the anti-correlation of their targets. C) Functional enrichment analysis of mRNA regulated by the 22 miRNAs displayed in Panel B.
Only mRNAs affected by RA-Diff and the Htt null mutation, as well as anti-correlated with respect to their miRNA regulators were selected for the
analysis. Enrichment FDR values are displayed in the bar chart.
https://doi.org/10.1371/journal.pgen.1007765.g008
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Mice
The lines of mice with the Hdhex4/5 and HdhneoQ20, HdhneoQ50 and HdhneoQ111 alleles, as well
as the genotyping protocols, and the relative levels of huntingtin expressed from a single
HdhneoQ20, HdhneoQ50 and HdhneoQ111 allele, relative to a single wild-type allele, as estimated
from immunoblot analysis of heterozygote ES cells or heterozygote brain tissue have been
reported previously [7,9,18]
For skeletal preparations, embryos and newborns mice were eviscerated, fixed in ethanol,
incubated in acetone and finally stained using alizarin red and alcian blue [53,54]. The in vivo
epidermal barrier assay was performed on E18.5 embryos using a dye exclusion assay as
reported [55]. Briefly, embryos were sacrificed, immersed in methanol solutions at different
concentrations, then stained in 0.1% toluidine blue and washed several times with PBS again
to remove the excess dye.
Immunohistological analyses
Staining with hematoxylin and eosin (H&E) and immunostaining was performed by fixing
frozen brain or skin sections [cryostat] (LEICA CM3050S), sectioned at 6 μm, in 4% Parafor-
maldehyde, incubating with primary antibodies at 4˚C overnight, while secondary antibody
were used following vendor instructions. Anti-Proliferating Cell Nuclear Antigen (PCNA) was
from Santa Cruz Biotechnology, Inc. Slides were rinsed and mounted using Vectashield with
4,6-diamidino-2-phenylindole (DAPI) (Vector Laboratories) for visualization of nuclei.
The DeadEnd Colorimetric TUNEL (TdT-mediated dUTP Nick-End Labeling) Assay (Pro-
mega) was used to detect apoptotic cells in situ accordingly to the vendor’s instructions.
Protein extraction and immunoblot analysis
Pools of 2 embryos at E18.5 were used for each of the three biological replicate. Total protein
lysates were prepared by pulverizing skin tissue and extracted using RIPA (Boston Bio-Prod-
ucts) lysis buffer with protease inhibitor mixture (Roche). After Bradford protein assay
(BIORAD), fifty micrograms subjected to 10% SDS–PAGE, transferred to nitrocellulose mem-
branes (Schleicher and Schuell) and incubated with the following primary antibodies: anti-
filaggrin (Covance), anti-loricrin (Covance) and anti-alpha tubulin antibody (Santa Cruz Bio-
technology, Inc).
Mouse and rabbit secondary antibodies were used and the specific protein bands were
detected using the ECL Plus kit (Pierce) and autoradiographic film (Hyperfilm ECL; Amer-
sham Bioscience).
Statistical analysis was performed using unpaired t-test with significance evaluated by
p value <0.05 (�) or <0.01 (��).
Whole mount in situ hybridization
After dissection in PBS, embryos were fixed overnight in 4% paraformaldehyde at 4˚C. RNA
in situ hybridizations were performed as described previously. Briefly, E11-11.5 mouse
embryos were fixed overnight in 4% formaldehyde in PBS, then dehydrated in methanol and
stored at -20˚C until use. The digoxigenin-labelled RNA probes were used at 0.5 ug/ml. Alka-
line phosphatase-conjugated anti-digoxigenin Fab fragments were used at 1:5000. Color reac-
tions were carried out over time periods ranging from 2 hours to overnight. Embryos were
mounted in 80% glycerol before being photographed. Three to four embryos were evaluated
for each marker.
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Flow cytometry
Fetal liver and fetal thymus were harvested from E14.5 and E18.5 WT and Hdhneo-inQ50/
Hdhex4/5 embryos and single cell suspensions were obtained by mechanical disruption. Fetal
liver cells were stained with Ter119, CD71, Mac-1, Gr-1 B220 and CD19, and thymocytes were
stained with CD4 and CD8a cell surface markers, respectively. Flow cytometry was performed
on a two-laser FACS Canto (BD Biosciences). FCS files were analyzed by FlowJo software
(Tree Star). Antibodies used were CD4 (L3T4), CD8a (53–6.7), CD19 (1D3), Mac-1 (M1/70),
B220 (RA3-6B2), Gr-1 (RB6-8C5), Ter119, CD71 (C2) (BD Pharmingen, eBioscience).
Colony forming cell (CFC) assays
Methylcellulose colony forming cell (CFC) assays was performed on fetal liver cells of E14.5
and E18.5 WT and Hdhneo-inQ50/Hdhex4/5 mice as previously described [56]. Briefly, 5 × 104
cells were cultured with Methocult M3434 (Stem Cell Technologies) supplemented with hTPO
(50 ng/ml) in 35-mm culture dishes (NUNC 174926) in duplicates. Colonies were scored from
day 2 to day 17 according to the technical manual and previously described criteria [57], and
were confirmed by May-Giemsa staining (Harleco) of cytospins (400 rpm, 5 min) of individual
colonies. Cytokines were purchased from R&D Systems. Statistical analysis was performed
using unpaired t-test with significance evaluated by p value <0.05 (�) or <0.01 (��).
Cell culture
Wild-type and huntingtin null Hdhex4/5/ex4/5 mouse embryonic stem cell lines were described
previously [9,12,58]. Differentiation was performed essentially as described in Bibel et al., 2007
[59]. In brief, ESCs were deprived of feeder cells for 4 passages, then 3 x (106) cells were used
for formation of embryoid bodies (EBs). EBs were grown in non-adherent bacterial dishes
(Greiner, Germany) for 8 days. Retinoic acid (5 μM, SIGMA) was added from day 4 to day 8
and medium was changed every other day. Subsequently, EBs were dissociated by trypsin
digestion and plated on Poly-Ornithine (SIGMA) and laminin (SIGMA) coated plates to
obtain RA-differentiated cells (RA-DIFF). Two hours after plating, RA-differentiated cells
were collected for different analyses.
RNA isolation and RNAseq, miRNAseq library preparation and sequencing
RNA was extracted from cell lines by using TRIzol reagent (Life technologies), following man-
ufacturer’s instructions. All RNA samples were subjected to DNAse I treatment (Ambion).
RNA sequencing was performed following the protocol described by the Broad Institute
(Cambridge, MA) [60,61]. Briefly, poly-A-plus mRNA, was retro-transcribe to cDNA using a
strand specific dUTP method, random hexamers and amplified by PCR using bar-coded DNA
adaptors from Illumina. HiSeq2000 platform and 50bp pair-end (PE) was used for sequencing
obtaining 50-75M reads/library.
Small RNA library preparation (mainly miRNAs) was obtained using the Illumina TruSeq
Small RNA protocol (Illumina) according to manufacturer instructions and libraries were
sequenced using single-end, 50bp reads on HiSeq2000 platform, obtaining 45-90M reads/
library.
RNA-Sequencing and miRNA-Sequencing data analysis
For RNA-Seq, 50 bp paired-end reads were aligned to the mouse genome (GRCm38.p4) with
Tophat (version 2.0.14, default settings), using the Gencode M6 transcript annotation as tran-
scriptome guide. All programs were used with default settings unless otherwise specified.
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Mapped reads (S1 Table) were assembled into transcripts guided by reference annotation
(Gencode M6) with Cufflinks (version 2.2.1). Expression levels were quantified by HTSeq
(Version 0.6.1,—mode intersection-nonempty) using Gencode M6 annotation. Normalization
was performed using the TMM method implemented in edgeR. Differential expression was
calculated using edgeR (dispersion 0.1, pval< 0.05, log2 fc>0.75, log2CPM > 0).
For miRNA-Seq, 50 bp single-end reads were trimmed against Illumina’s TruSeq Small
RNA 3’ (TGGAATTCTCGGGTGCCAAGG) and 5’ (GUUCAGAGUUCUACAGUCCGAC
GAUC) adapters using cutadapt (v. 1.3) with parameters–e 0.1 –O 5 –m 15 [62]. Next,
trimmed sequence reads with length of 16-25bp were mapped to 1915 known mature miRNA
sequences from miRBase (release 21) database [63], using BWA aln (v. 0.7.5a-r418) with
parameter–n 1 [64]. Uniquely mapped reads (S1 Table) were identified by selecting alignments
with non-zero mapping quality and “XT:A:U” tag using samtools (v 0.1.18) [65]. Normaliza-
tion was performed using the TMM method (BWA and TMM were suggested previously
[66]). Differential expression was calculated using edgeR (dispersion 0.1, pval < 0.05, log2 fc
>0.75, log2CPM > 0) [67].
Computational analyses
Functional annotation of gene lists and enrichment analysis with Gene Ontology terms and
KEGG or REACTOME pathways were performed with the clusterProfiler Bioconductor
package.
Neuron, astrocyte and oligodendrocyte markers were downloaded from Cahoy et al., 2008
[24], while lists of genes implicated in the different phenotypes were manually created based
on multiple papers/web-resources [43,68–73] (S2 Table). The significance of custom enrich-
ments was measured with one-sided Fisher exact test.
Collections of murine miRNA targets were downloaded from miRTarBase (Release 6.1)
[74]. For each miRNA–target mRNA couple, Pearson’s correlation values were calculated
from standard normalized expression values. For each miRNA, the negative shift in the distri-
bution of target correlation values was measured with one-sample one-sided Wilcoxon test
(significance threshold: P< 0.05).
Supporting information
S1 Fig. Morphological characterization of brain vasculature defects in Hdh hypomorhic
mice. A-B) Representative pictures of WT and HdhneoQ50/Hdhex4/5 embryos at E11.5 and
E14.5 developmental stages. Visible vasculature defects are present in animals, especially at the
level of the brain. Scale bars = 1000μm.
C) Representative pictures of coronal histological sections at the anterior (ANT), medial
(MED) and posterior (POS) levels of HdhneoQ50/Hdhex4/5 embryos brains confirm enlarged
ventricles with extensive blood accumulation. LV, lateral ventricles; 3rd, third ventricle, 4th
fourth ventricle. Scale bar = 500μm.
(TIF)
S2 Fig. The transcriptional changes induced by RA differentiation are quantitatively and
qualitatively similar in Htt wild-type and Hdhex4/5/ex4/5 cells. A) M (log ratio) and A (mean
average) (MA) plot representations of mRNA-seq pairwise comparisons of RA-DIFF cells by
wild-type (WT) or Hdhex4/5/ex4/5 Htt null (dKO) genotypes showing the average log10 signal
(Counts Per Million—CPM) against the log2 Fold Change (FC) for each gene. Genes signifi-
cantly up- regulated or down-regulated in the comparison are highlighted in red and blue,
respectively. Numbers of differentially expressed genes are displayed (parenthesis).
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B) The Venn diagram reports the total number of genes that are commonly or specifically dys-
regulated during differentiation (transition from ESC to RA-DIFF), comparing cells with Htt
wild-type (WT) or Htt-null (dKO) genotypes. C) MA plot representations of miRNA-seq pair-
wise comparisons. Legends, abbreviation and colors as in A). D) The Venn diagram reports
the total number of miRNAs that are commonly or specifically changed during RA differentia-
tion by wild-type (WT) or Hdhex4/5/ex4/5 Htt null (dKO) genotypes. E) Cluster 1 contains genes
that are highly expressed in ESC and whose expression decreases during RA differentiation.
Bar plots for this cluster report the most enriched GO-terms describing biological processes.
The number of genes within each GO-term is also indicated (number within bars). F) Cluster
2 groups genes that are poorly expressed in ESC, but strongly upregulated during RA differen-
tiation. Bar plots report the 5 most enriched GO terms associated with genes in Cluster 2. The
number of genes within each GO-term is also indicated (number within bars). Genes belong-
ing to Cluster 1 and 2 show similar behavior in cells with Htt wild-type (WT) or Htt-null
(dKO) genotypes.
(PDF)
S3 Fig. The transcriptional changes due to Hdhex4/5/ex4/5 null genotype are quantitatively
and qualitatively different in ESC and RA-DIFF cells and are milder compared to changes
by RA differentiation. A) M (log ratio) and A (mean average) (MA) plot representations of
mRNA-seq pairwise comparisons of Hdhex4/5/ex4/5 Htt null (dKO) versus wild-type (WT)
genotypes in ESC and RA-diff cells showing the average log10 signal (Counts Per Million—
CPM) against the log2 Fold Change (FC) for each gene. Genes significantly up- regulated or
down-regulated in the comparison are highlighted in red and blue, respectively. Numbers of
differentially expressed genes are displayed (parenthesis). B) The Venn diagram reports the
total number of genes that are commonly or specifically dysregulated comparing cells with Htt
wild-type (WT) or Htt-null (dKO) genotypes in ESC and RA-DIFF cells. C) MA plot represen-
tations of miRNA-seq pairwise comparisons. Legends, abbreviation and colors as in A). D)
The Venn diagram reports the total number of miRNAs that are commonly or specifically dys-
regulated comparing cells with Htt wild-type (WT) or Htt-null (dKO) genotypes in ESC and
RA-DIFF cells. E) Heatmap reports the top 25 most enriched Reactome and KEGG pathways
associated with genes up and down-regulated in ESC and RA-DIFF cells in absence of hun-
tingtin. The number of affected genes within each pathway is indicated (numbers in the cells).
(PDF)
S4 Fig. Hdhex4/5/ex4/5 null mutation alters expression of genes involved in neuron-glial spec-
ification. A) Expression trajectory plots describing variations in transcriptional levels of genes
involved in neuron-glial specification during RA-DIFF: transcriptional changes for neuron
markers, astrocyte markers, oligodendrocyte markers [24] between the two Htt genotypes
(wild-type = WT and Htt-null = dKO) and two developmental stages (ESC and RA-DIFF) are
shown. The number of genes defining each class of markers is indicated at the top of each plot.
B) Enrichment bar plots depicting the enrichment values of neuron, astrocyte and oligoden-
drocyte markers among the 4 gene classes (up_up; up_down; down_down; down_up, as
described in Fig 3A) of genes affected by RNA-differentiation and by Hdhex4/5/ex4/5 null muta-
tion. The number of genes enriched in each of the 4 classes is indicated within each column.
Statistical significance, measured by Fisher exact test is indicated by asterisks: (�) P<0.05, (���)
P<0.01.
(PDF)
Hypomorphic mutation of the mouse Huntington’s disease gene orthologue
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1007765 March 21, 2019 23 / 28
S1 Table. Table summarizes total number of raw and aligned reads for RNA-seq (A) and
miRNA-seq (B) experiments. Data are related to Fig 6 and S2 and S3 Figs.
(DOCX)
S2 Table. Table summarizes the source of the papers/webtools used to create the manually
annotated genes’ lists for genes-associated-phenotypes. Data are related to Fig 7 of the main
text.
(DOCX)
S1 File. The excel file comprizes two spreadsheet describing RNA-seq and miRNA-seq full
data. For each comparison a color code was used to highlight genes/miRNAs that were signifi-
cantly downregulated (red) or upregulated (green). Log2 CPM or Log2Fold Change (FC) val-
ues were obtained for each gene or miRNA.
RNA-seq: Gene symbol and Ensembl ID, gene type (protein coding or non-coding), full
description of the gene name, chromosomal and strand location as well as genomic coordi-
nates were described. For each gene its fitting to a functional enrichment class [up-up, up-
down, down-down, down-up] (see also Fig 6) or its role as neuron, astrocyte, oligodendrocy-
te_marker (see also S4 Fig) was reported, while its contribution to developmental phenotypes
(middle_ear_development, hematopoiesis, skeleton, skin, bodyweight) was presented in col-
umns I-Q. miRNA-seq: Similarly to what presented for genes, for each miRNA its belonging
to the functional enrichment class [up-up, up-down, down-down, down-up] (see also Fig 8)
was reported, while its previous correlation with HD mutation [Hoss_2015, Hoss_2014,
Lee_2011_1, Lee_2011_2, Marti_2010_1, Marti_2010_2] was assessed as described in columns
C-J.
(XLSX)
S2 File. The excel file has spreadsheets describing significant GO terms and pathways
(Reactome-Keggs) for the 10 different comparisons presented in Figs 6–8 [differentia-
tion_up, differentiation_down, HttdKO_ESC_up, HttdKO_ESC_down, HttdKO_RA-
DIFF_up, HttdKO_RA-DIFF_down, up-up, up-down, down-up, down-down). For each
comparison/spreadsheet the ontology ID and description, fold enrichment, P-value, False Dis-
covery rate (FDR) significance and annotated genes were reported.
(XLSX)
S3 File. The excel file summarizes the ChEA analysis related to Fig 8. For each ChEA data-
sets, the phenotype enrichment (middle_ear_development, hematopoiesis, skeleton, skin,
bodyweight), combined score, fold enrichment, p_value, False Discovery Rate (FDR) signifi-
cance and the annotated genes were described.
(XLSX)
S4 File. The excel file has spreadsheets describing: i. miRNAs with anticorrelated target;
ii. miRNAs target interactions; iii. enrichment analysis for UP_UP miRNAs targets and
iv. enrichment analysis for UP_DOWN miRNAs targets to support results presented in
Fig 8. For table describing miRNAs with anti-correlated targets, the miRNA ID, miR_class
(down_enhanced, down_counteracted), number of miRNAs annotated and anti-correlated
target genes, average Spearman and Pearson’s correlation and pvalue were reported. Simi-
larly, for miRNAs target interactions, the mRNA target ID and description, technical
evidence of miRNA-target interaction as well as its belonging to the developmental
phenotypes (middle_ear_development, hematopoiesis, skeleton, skin, bodyweight) were
described. Finally enrichment analysis for miRNAs targets, presenting ontology ID and
description, fold enrichment, P-value, False Discovery rate (FDR) significance and
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annotated genes were reported for UP_UP and UP_DOWN classes (see Fig 8 and results).
(XLSX)
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